These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 27877215)
1. The C-reactive Protein/Albumin Ratio Is an independent Prognostic Factor for Overall Survival in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy. Tao CJ; Chen YY; Jiang F; Feng XL; Jin QF; Jin T; Piao YF; Chen XZ J Cancer; 2016; 7(14):2005-2011. PubMed ID: 27877215 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566 [TBL] [Abstract][Full Text] [Related]
3. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma. Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304 [TBL] [Abstract][Full Text] [Related]
4. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127 [TBL] [Abstract][Full Text] [Related]
5. [Preoperative C-reactive protein/albumin ratio predicts the prognosis of patients with resectable pancreatic cancer]. Luo BY; Yang Y; Duan YF; Cai HH; An Y; Sun DL Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):712-717. PubMed ID: 30157579 [No Abstract] [Full Text] [Related]
6. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis. Gao N; Yang RN; Meng Z; Wang WH Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma. Yu ST; Zhou Z; Cai Q; Liang F; Han P; Chen R; Huang XM Onco Targets Ther; 2017; 10():879-884. PubMed ID: 28243123 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma. Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819 [TBL] [Abstract][Full Text] [Related]
9. The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients. Guo S; He X; Chen Q; Yang G; Yao K; Dong P; Ye Y; Chen D; Zhang Z; Qin Z; Liu Z; Xue Y; Zhang M; Liu R; Zhou F; Han H BMC Cancer; 2017 Mar; 17(1):171. PubMed ID: 28264659 [TBL] [Abstract][Full Text] [Related]
10. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma. Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731 [TBL] [Abstract][Full Text] [Related]
11. Exploration and Validation of C-Reactive Protein/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma. Zhang Y; Zhou GQ; Liu X; Chen L; Li WF; Tang LL; Liu Q; Sun Y; Ma J J Cancer; 2016; 7(11):1406-12. PubMed ID: 27471556 [TBL] [Abstract][Full Text] [Related]
12. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors. He X; Li JP; Liu XH; Zhang JP; Zeng QY; Chen H; Chen SL J Cancer; 2018; 9(10):1877-1884. PubMed ID: 29805715 [No Abstract] [Full Text] [Related]
14. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. Wu M; Guo J; Guo L; Zuo Q Tumour Biol; 2016 Sep; 37(9):12525-12533. PubMed ID: 27344157 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide. Topkan E; Besen AA; Mertsoylu H; Kucuk A; Pehlivan B; Selek U Int J Inflam; 2020; 2020():6947382. PubMed ID: 32566124 [TBL] [Abstract][Full Text] [Related]
16. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care. Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054 [No Abstract] [Full Text] [Related]
17. Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study. Murakawa M; Yamamoto N; Kamioka Y; Kamiya M; Kobayashi S; Ueno M; Morimoto M; Atsumi Y; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S In Vivo; 2020; 34(1):347-353. PubMed ID: 31882498 [TBL] [Abstract][Full Text] [Related]
18. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma. Xu XL; Yu HQ; Hu W; Song Q; Mao WM PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma. Huang H; Chen LM; Fang XJ; Guo CC; Lin XP; Hong HM; Li X; Wang Z; Tian Y; Chen MT; Yao YY; Chen Z; Li XQ; Pan F Front Pharmacol; 2020; 11():593392. PubMed ID: 33101044 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy. Koh YW; Lee HW Medicine (Baltimore); 2017 May; 96(19):e6848. PubMed ID: 28489774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]